← SynDRA
NAFTOPIDIL
SynDRA canonical compound SYN0004850 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ADRA1A | ADRA1D |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
| Indication | benign prostatic hyperplasia (BPH) |
|---|
| Disease area | urology |
|---|
All known targets
- ADRA1A
- ADRA1D
- ADRA1B
- ADRB2
- Adra1a
- Adra1b
- Adra1d
- Adra2a
- Adra2b
- Adra2c
Mechanisms of action (all sources)
- ADRA1D ANTAGONIST
- Alpha-1d adrenergic receptor antagonist
- adrenergic receptor antagonist
- ADRA1A INHIBITOR
- ADRA1A ANTAGONIST
- ADRA1B ANTAGONIST
Drug classes
- Adrenergic Agents
- Adrenergic alpha-Antagonists
- Adrenergic Antagonists
- Antihypertensive Agents
- Calcium Channel Blockers
- Calcium-Regulating Hormones and Agents
- Cardiovascular Agents
- Hematologic Agents
- Membrane Transport Modulators
- Neurotransmitter Agents
- Platelet Aggregation Inhibitors
Cross-references
Synonyms
- BM-15275
- KT-611
- avishot
- flivas
- naftopil
- naftopidil hydrochloride
- naftopidil dihydrochloride
- naftopidil HCl
- Flivas
- NSC-759293
- Naftopidil [INN]
- Avishot
- Naftopidilum [Latin]
- Naftopidil (Flivas)
- Naftopidil (unspecified)
- BRN 0629965
- CHEMBL142635
- C24H28N2O3
- 1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol
- NCGC00015718-06
- (+-)-1-(4-(2-Methoxyphenyl)piperazinyl)-3-(1-naphthyloxy)propan-2-ol
- 4-(2-Methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-1-pioerazineethanol
- (RS)-1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol
- DSSTox_RID_80725
- DSSTox_CID_25176
- Naftopidilum
- R9PHW59SFN
- NSC 759293
- DTXCID3025176
- RefChem:831691
- (+/-)-Naftopidil
- MFCD00242741
- SMR000466346
- CAS-57149-07-2
- UNII-R9PHW59SFN
- Avishot;
- Flivas (TN)
Look up NAFTOPIDIL in the interactive SynDRA portal →